Welcome to our dedicated page for Medical Care Technologies news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on Medical Care Technologies stock.
Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (OTC Pink: MDCE) reported ongoing rigorous testing of its MDCE Melanoma Scan Beta AI imaging platform as of August 3, 2026. The company is conducting structured evaluation and model training using multi-phase testing protocols that emphasize image quality, consistency, and performance across varied datasets, aiming to refine its proprietary AI vision systems.
In parallel, Medical Care Technologies continues to operate a diversified business model with revenue-generating subsidiaries and consumer applications. The company is evaluating selective partnerships and potential brand acquisitions aligned with its software development, AI vision, and digital platform capabilities, while seeking to balance technical development, monetization, and strategic growth.
Medical Care Technologies (OTC Pink:MDCE) reported broader monetization of its technology portfolio, generating revenue from mobile apps, enterprise web solutions, AI vision systems, and backend logistics software while advancing its core medical imaging tools, including the MDCE Melanoma Scan Beta and MDCE Wound Monitor applications.
According to Medical Care Technologies, its Snapshot Recipes app is nearing 1,000 users, Infinite Auctions has processed nearly $25 million in lifetime sales, and Real Game Used has authenticated over $35 million in sports and entertainment memorabilia, supporting a diversified, revenue-focused model complemented by ongoing AI model training and potential partnership and brand acquisition evaluations.
Medical Care Technologies (OTC PINK:MDCE) reported a major technical progression of its proprietary AI vision platform, now significantly beyond the scope of its July 2025 U.S. Provisional Patent Application No. 63/854,935. The company therefore chose not to continue prosecuting that earlier filing, stating its technology has leapfrogged the original disclosures.
MDCE is focusing on newly trained, continuously learning AI models that adapt to changing data and environments. These models are intended to support consumer, medical-grade, and enterprise-level visual identification, quality control, and imaging analysis, spanning healthcare imaging, agricultural quality monitoring, and broader industrial visual analysis applications.
Medical Care Technologies (OTC PINK:MDCE) reported that its wholly owned subsidiary, Infinite Auctions, completed an online auction using the company's new proprietary auction software platform. The event generated approximately $125,000 in proceeds from sales of company-owned inventory.
According to Medical Care Technologies, the funds will be used to reduce outstanding debt and support ongoing operations tied to its AI vision technology platforms. Management highlighted that this represents non-dilutive capital raised through liquidation of assets as the company works to strengthen its balance sheet and advance AI-focused technology initiatives across its diversified portfolio.
Medical Care Technologies (OTC PINK:MDCE), through its wholly owned subsidiary Infinite Auctions, is in the final hours of a Game Used Flash Auction featuring rare, photo-matched NBA memorabilia. Bidding closes on Saturday, July 25 at 10:00 PM Eastern Time.
Headline lots include an April 12, 2014 game-used, photo-matched Miami Heat LeBron James jersey with an NBA/MeiGray letter of authenticity, an Allen Iverson 2006 photo-matched and signed Philadelphia 76ers road jersey, and Kobe Bryant’s photo-matched, dual-signed Adidas “The Kobe 1” sneakers from Game 5 of the 2001 NBA Finals. The auction also offers Carmelo Anthony’s photo-matched jersey from his final game as a New York Knick. Infinite Auctions operates a proprietary online platform for premium sports and entertainment memorabilia.
Medical Care Technologies (OTC PINK:MDCE), through its wholly-owned subsidiary Infinite Auctions, is running a Game Used Flash Auction that closes on Saturday, July 25, 2026 at 10:00 PM Eastern Time. The event features high-profile, photo-matched, game-worn memorabilia from LeBron James, Kobe Bryant, Allen Iverson, and Carmelo Anthony.
Highlighted lots include LeBron James’ April 12, 2014 Miami Heat away jersey from the game that secured his 10th season averaging at least 25 points, 5 rebounds, and 5 assists, Kobe Bryant’s Game 5 sneakers from the 2001 NBA Finals clincher, a rare photo-matched Allen Iverson 76ers road jersey, and Carmelo Anthony’s jersey from his final game as a New York Knick. Bidding and the full catalog are available at Infinite Auctions’ online platform.
Medical Care Technologies (OTC PINK:MDCE) has expanded its advanced internal evaluation framework for its proprietary AI imaging platform. The company is deploying a more rigorous, multi-phase testing architecture to systematically assess technical performance, including quantitative image quality metrics, end-to-end workflow efficiency in varied clinical simulations, and longitudinal tracking accuracy across sequential imaging datasets.
The enhanced processes use structured benchmarking, iterative model refinement, and controlled validation cycles to reinforce the platform’s technical foundation as development progresses. According to Medical Care Technologies, these initiatives align with its commitment to technical credibility and complement revenue-generating subsidiaries Infinite Auctions and Real Game Used within its diversified operating structure.
Medical Care Technologies (OTC PINK:MDCE), via its wholly-owned subsidiary Infinite Auctions, is promoting its summer sports memorabilia auction featuring an Allen Iverson game-used, photo-matched, signed 76ers road jersey, currently at a $20,000 bid, and multiple Vince Carter game-worn pieces. The online auction closes Saturday, July 25, 2026, at 9:00 PM EDT.
Medical Care Technologies (OTC:MDCE) reported that on July 17, 2026 it ranked as the #1 Top OTC Volume Leader, with approximately 476 million shares traded, according to market data. The company links this record share volume to growing market interest in its diversified operations.
According to Medical Care Technologies, its strategy combines an AI vision platform and healthcare initiatives with revenue-generating subsidiaries Infinite Auctions and Real Game Used, which operate in sports and entertainment collectibles. Its AI technology is deployed in consumer apps like Snapshot Recipes and used for authentication at Real Game Used, while internal testing continues for the MDCE Melanoma Scan Beta and wound monitoring applications.
Medical Care Technologies (OTC PINK: MDCE) reported ongoing revenue momentum from wholly-owned subsidiaries Infinite Auctions and Real Game Used while progressing its AI vision healthcare initiatives. Infinite Auctions is running a live online auction of high-profile sports memorabilia, scheduled to close Saturday, July 25, and Real Game Used is seeing rising use of its automated photo-match authentication platform alongside increased traditional authentication submissions.
According to the company, its core AI vision technology is deployed in consumer apps such as Snapshot Recipes and is being used for internal testing of the MDCE Melanoma Scan Beta platform and advanced image analysis APIs. The same AI tools are being developed for wound monitoring opportunities in the multi-billion dollar wound care market. MDCE describes a multi-pronged strategy spanning early detection, quality monitoring, and enterprise imaging solutions, supported by complementary revenue-generating subsidiaries.